Cited 0 time in
The impact of G-CSF on mouse immune cells in alcoholic liver disease, focusing on variations in T cells and their subsets
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, Sehee | - |
| dc.contributor.author | Perumalsamy, Haribalan | - |
| dc.contributor.author | Kim, Ji Eun | - |
| dc.contributor.author | Kim, Hye Young | - |
| dc.contributor.author | Jun, Dae Won | - |
| dc.contributor.author | Yoon, Tae Hyun | - |
| dc.date.accessioned | 2026-03-12T01:00:26Z | - |
| dc.date.available | 2026-03-12T01:00:26Z | - |
| dc.date.issued | 2024-09 | - |
| dc.identifier.issn | 0753-3322 | - |
| dc.identifier.issn | 1950-6007 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/211209 | - |
| dc.description.abstract | Alcoholic liver disease (ALD) significantly affects immune cell function and leads to immunological dysregulation. This study explored the potential of granulocyte colony-stimulating factor (G-CSF) to mitigate the negative effects of alcohol on immune cells in a mouse model of ALD. To investigate the capacity of G-CSF, ALD was induced using a 17-day alcohol-enriched diet, followed by a single G-CSF dose prior to sampling. We focused on the dynamics of peripheral blood mononuclear cells using high-dimensional mass cytometry to detect subtle changes. Alcohol intake reduced the number of B cells, monocytes, dendritic cells, and NK cells while increasing the number of T cells. Notably, G-CSF treatment reversed the alcohol-induced increase in total CD4+ and CD8+ T cell populations. This effect was remarkable in naïve, effector CD4+ T cells and naïve CD8+ T cells. PhenoGraph and FlowSOM analysis further revealed the recovery effect of G-CSF on specific T cell subgroups, including central memory CD8+ T cells and double-negative T cells expressing Ly6chighCD44high, which are adversely affected by alcohol. These results enhance our understanding of the effect of ALD on immune function and suggest that G-CSF is a potential therapeutic agent, laying the foundation for future clinical research. | - |
| dc.format.extent | 11 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier Masson | - |
| dc.title | The impact of G-CSF on mouse immune cells in alcoholic liver disease, focusing on variations in T cells and their subsets | - |
| dc.type | Article | - |
| dc.publisher.location | 프랑스 | - |
| dc.identifier.doi | 10.1016/j.biopha.2024.117175 | - |
| dc.identifier.scopusid | 2-s2.0-85199806544 | - |
| dc.identifier.wosid | 001284173000001 | - |
| dc.identifier.bibliographicCitation | Biomedicine & Pharmacotherapy, v.178, pp 1 - 11 | - |
| dc.citation.title | Biomedicine & Pharmacotherapy | - |
| dc.citation.volume | 178 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 11 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Research & Experimental Medicine | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | granulocyte colony stimulating factor | - |
| dc.subject.keywordAuthor | ALD | - |
| dc.subject.keywordAuthor | Granulocyte | - |
| dc.subject.keywordAuthor | Granulocyte colony-stimulating factor (G-CSF) | - |
| dc.subject.keywordAuthor | Mass cytometry | - |
| dc.subject.keywordAuthor | T cell | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S075333222401059X?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
